Nwobi, Obioma <br/><br/>
Rituximab therapy for juvenile-onset systemic lupus erythematosus.  [electronic resource] 

 -  Pediatric nephrology (Berlin, Germany)  Mar 2008 
 - 413-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0931-041X 
<br/><br/><label>Standard No.: </label>10.1007/s00467-007-0694-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived<br/>Child<br/>Female<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Male<br/>Retrospective Studies<br/>Rituximab